EGX disclosure announcing the acquisition of a generic anti-inflammatory analgesic molecule Regulatory DisclosuresBy adminApril 1, 2020
EGX disclosure regarding the upcoming OGM on 25 March 2020 Regulatory DisclosuresBy adminMarch 1, 2020
Disclosure to EGX on BOD and shareholding structure as of 31 December 2019 Regulatory DisclosuresBy adminJanuary 14, 2020
